In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin

In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin

Major physiological changes are governed by alternative splicing of RNA, and its misregulation may lead to specific diseases. With the use of a genome-wide approach, we show here that this splicing step can be modified by medication and demonstrate the effects of the biguanide metformin, on alternat...

Full description

Bibliographic Details
Main Authors: Delphine Laustriat, Jacqueline Gide, Laetitia Barrault, Emilie Chautard, Clara Benoit, Didier Auboeuf, Anne Boland, Christophe Battail, François Artiguenave, Jean-François Deleuze, Paule Bénit, Pierre Rustin, Sylvia Franc, Guillaume Charpentier, Denis Furling, Guillaume Bassez, Xavier Nissan, Cécile Martinat, Marc Peschanski, Sandrine Baghdoyan
Format: Article
Language:English
Published: Elsevier 2015-01-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
alternative splicing
AMPK
Metformin
myotonic dystrophy type 1
RBM3
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253116300476

Internet

http://www.sciencedirect.com/science/article/pii/S2162253116300476

Similar Items